Lv1
10 积分 2025-08-11 加入
Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1–9 years: two phase 2 randomised, controlled, observer-blinded studies
1天前
待确认
[A phase Ⅲ clinical trial study on the safety and immunogenicity of ACYW135 group meningococcal conjugate vaccine inoculated in 3 month old infants]
1个月前
已完结
IL25 elicits a multipotent progenitor cell population that promotes TH2 cytokine responses
1个月前
已完结
[Study on the safety and immunogenicity of ACYW135 meningococcal polysaccharide conjugate vaccine in children aged 4-6 years]
1个月前
已完结
[Research progress on immunogenicity evaluation of serogroup B meningococcal vaccine]
5个月前
已完结
Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial
5个月前
已完结
Immunogenicity and protective capacity of a CpG ODN adjuvanted alum adsorbed bivalent meningococcal outer membrane vesicle vaccine
5个月前
已完结
Meningococcal Vaccination in the United States: Past, Present, And Future
5个月前
已完结
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial
6个月前
已完结
A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial
6个月前
已关闭
皖公网安备34019202002308
